Leerink Partnrs restated their outperform rating on shares of Immunome (NASDAQ:IMNM – Free Report) in a research report released on Monday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for Immunome’s Q4 2023 earnings at ($0.25) EPS, FY2023 earnings at ($0.50) EPS, Q1 2024 earnings at ($1.05) EPS, Q2 2024 earnings at ($0.12) EPS, Q3 […]
Dorsey Wright & Associates purchased a new position in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The firm purchased 3,100 shares of the company’s stock, valued at approximately $26,000. Several other large investors also recently modified their holdings of IMNM. Natixis bought a new position in Immunome in […]
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,990,000 shares, an increase of 8.2% from the December 31st total of 1,840,000 shares. Based on an average trading volume of 228,800 shares, the […]
Shares of Immunome, Inc. (NASDAQ:IMNM – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $18.87 and last traded at $18.87, with a volume of 5944 shares changing hands. The stock had previously closed at $17.48. Wall Street Analyst Weigh In A number of […]
Immunome, Inc. (NASDAQ:IMNM – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $18.87 and last traded at $18.87, with a volume of 5944 shares traded. The stock had previously closed at $17.48. Wall Street Analysts Forecast Growth A number of brokerages have weighed in […]